Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 609 pages report, published by Global Markets Direct

Report ThumbnailJune-2017
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape.

Bile duct cancer or cholangiocarcinoma are tumors that occur in the bile duct. Symptoms include discomfort in the tummy area (abdomen), loss of appetite, high temperatures (feve

Read More
  • List of Figures
  • Number of Products under Development for Bile Duct Cancer (Cholangiocarcinoma), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Routes of Ad
Read More
  • List of Tables
  • Number of Products under Development for Bile Duct Cancer (Cholangiocarcinoma), H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Products under Development b
Read More
  • Table of Contents
  • Table of Contents 2
  • Introduction 6
  • Bile Duct Cancer (Cholangiocarcinoma) - Overview 7
  • Bile Duct Cancer (Cholangiocarcinoma) - Therapeutics Development 8
  • Bile Duct Cancer (Cholangiocarcinoma) - Therapeutics Assessment 22
  • Bile Duct Cancer (Cholangiocarcinoma) - Companies Involved in Therapeutics Development 36
  • Bile Duct Cancer (Cholangiocarcinoma) - Drug Profiles 70
  • Bile Duct Cancer (Cholangiocarcinoma) - Dormant Projects 584
  • Bile Duct Cancer (Cholangiocarcinoma) - Discontinued P
Read More

Please select a license type

Share

Related Products

Global Markets DirectBile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017Product ThumbnailBile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2017, Industry ReportProduct #: 829003
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved